These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Suitability of saphenous vein graft lesions for the use of distal embolic protection devices. Mehta SK, Stolker JM, Frutkin AD, Marso SP. J Invasive Cardiol; 2008 Nov; 20(11):568-70. PubMed ID: 18987394 [Abstract] [Full Text] [Related]
5. Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry). Mehta SK, Frutkin AD, Milford-Beland S, Klein LW, Shaw RE, Weintraub WS, Krone RJ, Anderson HV, Kutcher MA, Marso SP, American College of Cardiology-National Cardiovascular Data Registry. Am J Cardiol; 2007 Oct 01; 100(7):1114-8. PubMed ID: 17884373 [Abstract] [Full Text] [Related]
10. Clinical and economic outcomes of embolic complications and strategies for distal embolic protection during percutaneous coronary intervention in saphenous vein grafts. Senter SR, Nathan S, Gupta A, Klein LW. J Invasive Cardiol; 2006 Feb 09; 18(2):49-53. PubMed ID: 16446515 [Abstract] [Full Text] [Related]
15. Poor long-term patient and graft survival after primary percutaneous coronary intervention for acute myocardial infarction due to saphenous vein graft occlusion. Brodie BR, VerSteeg DS, Brodie MM, Hansen C, Richter SJ, Stuckey TD, Gupta N, Pulsipher M, Downey W. Catheter Cardiovasc Interv; 2005 Aug 01; 65(4):504-9. PubMed ID: 15988742 [Abstract] [Full Text] [Related]
16. Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era. Pucelikova T, Mehran R, Kirtane AJ, Kim YH, Fahy M, Weisz G, Lansky AJ, Moussa I, Gray WA, Collins MB, Kodali SK, Stone GW, Moses JW, Leon MB, Dangas G. Am J Cardiol; 2008 Jan 01; 101(1):63-8. PubMed ID: 18157967 [Abstract] [Full Text] [Related]
17. Failure of the Symbiot PTFE-covered stent to reduce distal embolization during percutaneous coronary intervention in saphenous vein grafts. Blackman DJ, Choudhury RP, Banning AP, Channon KM. J Invasive Cardiol; 2005 Nov 01; 17(11):609-12. PubMed ID: 16264208 [Abstract] [Full Text] [Related]
18. Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention. Chu WW, Rha SW, Kuchulakanti PK, Cheneau E, Torguson R, Pinnow E, Alexieva-Fournadjiev J, Pichard AD, Satler LF, Kent KM, Lindsay J, Waksman R. Am J Cardiol; 2006 Jan 01; 97(1):34-7. PubMed ID: 16377280 [Abstract] [Full Text] [Related]
19. Morphometric analysis of particulate debris extracted by four different embolic protection devices from coronary arteries, aortocoronary saphenous vein conduits, and carotid arteries. Quan VH, Huynh R, Seifert PA, Kuchela A, Chen WH, Sütsch G, Eisenhauer AC, Rogers C. Am J Cardiol; 2005 Jun 15; 95(12):1415-9. PubMed ID: 15950562 [Abstract] [Full Text] [Related]
20. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients. Coolong A, Baim DS, Kuntz RE, O'Malley AJ, Marulkar S, Cutlip DE, Popma JJ, Mauri L. Circulation; 2008 Feb 12; 117(6):790-7. PubMed ID: 18212287 [Abstract] [Full Text] [Related] Page: [Next] [New Search]